MedTrace Logo

Horizontal Ridge Augmentation Using Polyvinylidene Fluoride Versus Titanium Mesh Membranes

NCT07095530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-07-31

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of a new PVDF non-resorbable membrane versus Titanium Mesh in the treatment of horizontal ridge defects prepared for implant placement

Conditions

  • Horizontal Alveolar Bone Loss

Interventions

PROCEDURE

titanium membrane

surgical treatment for horizontal ridge augmentation by titanium mesh and PVDF membrane

Sponsors & Collaborators

  • Minia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-01-17
Completion
2025-01-20

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07095530 on ClinicalTrials.gov